Latest news with #CenterOfExcellence
Yahoo
26-06-2025
- Business
- Yahoo
Globant Opens Middle East Headquarters Amidst Soaring Regional Revenue
Globant (NYSE:GLOB) is one of the best mid cap growth stocks to invest in now. Towards the end of May, Globant officially inaugurated its Middle East Regional Headquarters in Riyadh, Saudi Arabia. This milestone came less than 3 years after Globant's initial entry into the region, which underscores its commitment to the Middle Eastern market and its ambition to lead digital reinvention through cutting-edge AI solutions and digital customer experiences. In Q1 2025, Globant's revenue in the Middle East & APAC region saw an 84.4% year-over-year increase. According to Gartner, IT spending in the MENA region is projected to grow by 7.4% to reach $230.7 billion in 2025. Specifically in Saudi Arabia, IDC forecasts that IT services spending will grow at a CAGR of 9% between 2022 and 2027, and ultimately reach $6.4 billion. A close-up of an experienced game engineer's hands typing a complex code on a laptop. Located in Building 1.15 KAFD, Globant's new headquarters also houses its third global Playground. The immersive and open space is designed to connect Middle Eastern tech leaders with future innovations through hands-on experiences blending sports, AI, and customer engagement. Previous Playgrounds have been successfully launched in São Paulo, Brazil, and Los Angeles, USA. The Riyadh hub will function as a Center of Excellence for AI and advanced digital solutions. Globant (NYSE:GLOB) provides technology services worldwide. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. While we acknowledge the potential of GLOB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Zawya
23-06-2025
- Health
- Zawya
Nabta Health unveils first-of-its-kind center of excellence for tailored women's care
The center represents the future of women's healthcare - where collaboration meets personalisation, and where every woman receives care as unique as she is Dubai, UAE - Nabta Health, the region's leading hybrid healthcare company dedicated to women's health, is proud to announce the launch of its groundbreaking Center of Excellence — the first of its kind in the region. This world-class facility is based at CMC Hospital and will offer integrated, female-focused care across fertility, pregnancy, perinatal support, and menopause. The Center of Excellence recognises that women's health extends far beyond traditional boundaries. The innovative model is built on a multi-specialty collaboration, uniting gynaecologists, endocrinologists, cardiologists, mental health professionals, and other experts under one roof to deliver truly integrated care that reflects the complex and interconnected nature of a woman's health. What sets the center apart is its commitment to age, stage, and goal-specific care, recognising that every stage of a woman's life brings unique health needs. The integrated care teams deliver personalised treatment plans that evolve over time, whether it's supporting a 25-year-old preparing for pregnancy, a 45-year-old navigating perimenopause, or a 65-year-old focused on healthy ageing. From fertility optimisation to menopause management and beyond, we offer comprehensive care that adapts to each woman's individual journey. This holistic approach ensures that conditions like PCOS, endometriosis, cardiovascular disease, and hormonal imbalances are managed in an integrated manner rather than in isolation. By coordinating care across multiple specialties and tailoring interventions to each woman's specific life stage and health goals, the center moves beyond symptom management and empowers women to achieve optimal health and well-being at every stage of life. "For too long, women have been forced to navigate a fragmented healthcare system that treats symptoms in isolation rather than addressing the whole person," said Sophie Smith, Founder and CEO of Nabta Health."Our Clinical Center of Excellence represents a fundamental shift, where collaboration replaces silos, where personalisation trumps one-size-fits-all approaches, and where every woman receives care that honours her unique journey and aspirations." 'This partnership exemplifies our commitment to pioneering healthcare excellence. By combining CMC's world-class facilities and clinical expertise with NABTA's innovative approach to women's health, we're creating a new standard of care that will serve as a model for the region and beyond,' said Mark Adams, CEO at CMC Hospital. Nabta Health's Center of Excellence marks a significant advancement in women's healthcare and reinforces Nabta Health's commitment to innovation and improving health outcomes for women throughout the region. About Nabta Health: Nabta Health is a pioneering women's healthcare company based in Dubai, dedicated to empowering women to take control of their health through accessible, comprehensive, and personalized healthcare solutions. We seamlessly blend the convenience of online healthcare with the expertise of in-person clinics, ensuring women in Dubai receive the best care possible. About CMC Hospital: CMC Hospital is a premier private healthcare institution in the UAE, offering world-class medical services across a broad spectrum of specialties. Affiliated with Clemenceau Medical Center in Beirut and part of the Clemenceau Medicine International network, CMC Hospital combines cutting-edge technology, internationally trained physicians, and patient-centric care to deliver the highest standards of medical excellence. With state-of-the-art facilities and a commitment to clinical innovation, CMC Hospital continues to set benchmarks in healthcare delivery both regionally and globally.
Al Bawaba
12-05-2025
- Health
- Al Bawaba
WCM-Q declared a Center of Excellence by leading diabetes body
Weill Cornell Medicine-Qatar (WCM-Q) has become the first medical institution in Qatar to receive official designation as an International Diabetes Federation Center of Excellence for diabetes care, research and education. It joins an elite group of 25 other centers of excellence across the world. To be designated a center of excellence, WCM-Q had to meet stringent eligibility criteria set by the International Diabetes Federation, including having state-of-the-art infrastructure for providing education, a track record of high-quality diabetes research, and status as a clinical institution with a multidisciplinary team of health professionals actively involved in diabetes care, prevention and advocacy. The International Diabetes Federation is the global voice of the diabetes community. It is a non-profit umbrella organization of 251 national diabetes associations in 158 countries and territories, working together to improve and empower the lives of the estimated 590 million people living with diabetes and prevent diabetes in those at risk. Leading WCM-Q diabetes researcher Dr. Rayaz Malik, professor of medicine and assistant dean for clinical research partnerships, said: 'We are very pleased to be designated an International Diabetes Federation center of excellence in recognition of our contribution to global diabetes research and education. This strengthens our capacity to undertake research in diabetes and its complications and enables WCM-Q to deliver education to health care professionals that will improve the diagnosis and management of people with diabetes and those at risk of developing diabetes. By working closely with organizations like the International Diabetes Federation we can help prevent the development of diabetes and improve the lives of those with diabetes.' Dr. Malik explained that in their recent systematic review published in the Lancet Diabetes Endocrinology, a 20-29 percent weight loss was shown to be associated with partial remission of diabetes in approximately 70 percent of people with type 2 diabetes. Furthermore, regular screening to identify early complications affecting the nerves, eyes and kidneys can prevent or limit blindness, dialysis and amputation. Dr. Javaid Sheikh, dean of WCM-Q, said: 'Designation as a Centre of Excellence by the International Diabetes Federation is a great honor for WCM-Q. Diabetes is perhaps the most pressing health concern for our region and WCM-Q is pursuing a multifaceted approach to tackling the condition through world-class research, clinical excellence, educational initiatives, and patient advocacy.'
